Author

Luke N. Redlon

Van Andel InstituteORCID 0009-0005-9199-8084Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:rat· 1 Approach:statistical model· 1

Frequent Co-Authors

Abigail E. EllisiD· 1 shared Carrie R. GraveeliD· 1 shared Curt J. EssenburgiD· 1 shared Elizabeth A. Tovar· 1 shared Evan C. LieniD· 1 shared Ian BeddowsiD· 1 shared Matthew R. SteensmaiD· 1 shared Patrick S. DischingeriD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abigail E. EllisORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular MetabolismPeer-reviewedJan 10, 2024

NF1 deficiency drives metabolic reprogramming in ER+ breast cancer

Rachel J. House, Elizabeth A. Tovar, Luke N. Redlon…·Matthew R. Steensma

This study investigates how NF1 deficiency affects metabolic reprogramming in ER+ breast cancer and identifies potential therapeutic synergies between metabolic and targeted inhibitors.

15 citations

ratbulk RNA-seq

𝕏 PostBluesky